Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
Darren K. McGuire, Nikolaus Marx, Sharon L. Mulvagh, John Eric Deanfield, Silvio E. Inzucchi, Rodica Pop‐Busui, Johannes F.E. Mann, Scott S. Emerson, Neil R Poulter, Mads D.M. Engelmann, Maria Sejersten Ripa, G. Kees Hovingh, Kirstine Brown‐Frandsen, Stephen Charles Bain, Matthew Aaron Cavender, Mette Gislum, Jens‐Peter David, John B. Buse
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1056/nejmoa2501006
- Published
- Mar 29, 2025
- Venue
- New England Journal of Medicine
- DOI
- 10.1056/nejmoa2501006
- PubMed
- 40162642
- Categories
- Diabetes Treatment and Management
- Provenance
- openalex